Crossmark

Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults

Crossref DOI link: https://doi.org/10.1016/j.eimce.2017.01.030

Published Print: 2017-02

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Rivero, Antonio

Pérez-Molina, José Antonio

Blasco, Antonio Javier

Arribas, José Ramón

Crespo, Manuel

Domingo, Pere

Estrada, Vicente

Iribarren, José Antonio

Knobel, Hernando

Lázaro, Pablo

López-Aldeguer, José

Lozano, Fernando

Moreno, Santiago

Palacios, Rosario

Pineda, Juan Antonio

Pulido, Federico

Rubio, Rafael

de la Torre, Javier

Tuset, Montserrat

Gatell, Josep M.
License Information

Text and Data Mining valid from 2017-02-01
More Information

This article is maintained by: Elsevier

Article Title: Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults

Journal Title: Enfermedades infecciosas y microbiologia clinica (English ed.)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.eimce.2017.01.030

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.eimc.2016.06.013

Content Type: article

Copyright: © 2016 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Mirobiologia Clinica. All rights reserved.

Document is current

Any future updates will be listed below